These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 19838454

  • 1. Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Blot S, Memon JI.
    Saudi Med J; 2009 Oct; 30(10):1366-7; author reply1366-7. PubMed ID: 19838454
    [No Abstract] [Full Text] [Related]

  • 2. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X.
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [Abstract] [Full Text] [Related]

  • 3. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 4. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee NY, Huang WH, Tsui KC, Hsueh PR, Ko WC.
    Diagn Microbiol Infect Dis; 2011 May; 70(1):150-3. PubMed ID: 21398070
    [Abstract] [Full Text] [Related]

  • 5. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F, Ak K, Kucukbasmaci O, Samasti M.
    Chemotherapy; 2009 Sep; 55(4):293-7. PubMed ID: 19521075
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 8. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ, Rojtman A, Tran K.
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
    [Abstract] [Full Text] [Related]

  • 9. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Lin JC, Siu LK, Fung CP, Yeh KM, Chang FY.
    J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
    [Abstract] [Full Text] [Related]

  • 10. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S, Muniandy S, Navaratnam P.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [Abstract] [Full Text] [Related]

  • 11. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 17; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract] [Full Text] [Related]

  • 12. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM, Jamal W, Rotimi VO, Evans JT, Hawkey PM.
    Int J Antimicrob Agents; 2009 May 17; 33(5):487-9. PubMed ID: 19097760
    [No Abstract] [Full Text] [Related]

  • 13. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.
    Clin Infect Dis; 2001 Apr 15; 32(8):1162-71. PubMed ID: 11283805
    [Abstract] [Full Text] [Related]

  • 14. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z, Zhu D, Zhang Y, Wang F.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1476-9. PubMed ID: 12509910
    [Abstract] [Full Text] [Related]

  • 15. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR, Saxena AK, Al-Ghamdi AM.
    Saudi Med J; 2004 Dec 10; 25(12):1871-6. PubMed ID: 15711657
    [Abstract] [Full Text] [Related]

  • 16. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
    Jeong SH, Bae IK, Kwon SB, Lee JH, Jung HI, Song JS, Jeong BC, Kim SJ, Lee SH.
    Lett Appl Microbiol; 2004 Dec 10; 39(1):41-7. PubMed ID: 15189286
    [Abstract] [Full Text] [Related]

  • 17. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
    Markovska R, Schneider I, Keuleyan E, Bauernfeind A.
    Clin Microbiol Infect; 2004 Aug 10; 10(8):752-5. PubMed ID: 15301679
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, Villasís-Keever A, Galindo-Fraga A, Palacios GM, Ponce-de-León A, Sifuentes-Osornio J.
    Int J Infect Dis; 2008 Nov 10; 12(6):653-9. PubMed ID: 18511321
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N.
    J Hosp Infect; 2008 Feb 10; 68(2):108-15. PubMed ID: 18063198
    [Abstract] [Full Text] [Related]

  • 20. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A, Bailey TC, Fraser VJ.
    Clin Infect Dis; 2008 Apr 15; 46(8):1322-3. PubMed ID: 18444877
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.